144 related articles for article (PubMed ID: 23335982)
1. A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
de Almeida RA; Fogli A; Gaillard M; Scheper GC; Boesflug-Tanguy O; Pavitt GD
PLoS One; 2013; 8(1):e53958. PubMed ID: 23335982
[TBL] [Abstract][Full Text] [Related]
2. Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation.
Gomez E; Pavitt GD
Mol Cell Biol; 2000 Jun; 20(11):3965-76. PubMed ID: 10805739
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the alpha subunit of eIF2B provides insights into the role of eIF2B bodies in translational control and VWM disease.
Norris K; Hodgson RE; Dornelles T; Allen KE; Abell BM; Ashe MP; Campbell SG
J Biol Chem; 2021; 296():100207. PubMed ID: 33334879
[TBL] [Abstract][Full Text] [Related]
4. Identification of a regulatory subcomplex in the guanine nucleotide exchange factor eIF2B that mediates inhibition by phosphorylated eIF2.
Yang W; Hinnebusch AG
Mol Cell Biol; 1996 Nov; 16(11):6603-16. PubMed ID: 8887689
[TBL] [Abstract][Full Text] [Related]
5. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange.
Pavitt GD; Ramaiah KV; Kimball SR; Hinnebusch AG
Genes Dev; 1998 Feb; 12(4):514-26. PubMed ID: 9472020
[TBL] [Abstract][Full Text] [Related]
6. Dynamic cycling of eIF2 through a large eIF2B-containing cytoplasmic body: implications for translation control.
Campbell SG; Hoyle NP; Ashe MP
J Cell Biol; 2005 Sep; 170(6):925-34. PubMed ID: 16157703
[TBL] [Abstract][Full Text] [Related]
7. A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.
Marom L; Ulitsky I; Cabilly Y; Shamir R; Elroy-Stein O
PLoS One; 2011; 6(10):e26992. PubMed ID: 22073122
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in the nucleotide exchange factor eIF2B constitutively activates the integrated stress response by allosteric modulation.
Boone M; Wang L; Lawrence RE; Frost A; Walter P; Schoof M
Elife; 2022 Apr; 11():. PubMed ID: 35416150
[TBL] [Abstract][Full Text] [Related]
9. Protection of eIF2B from inhibitory phosphorylated eIF2: A viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response.
Ito T; Wuerth JD; Weber F
J Biol Chem; 2023 Nov; 299(11):105287. PubMed ID: 37742919
[TBL] [Abstract][Full Text] [Related]
10. Viral evasion of the integrated stress response through antagonism of eIF2-P binding to eIF2B.
Schoof M; Wang L; Cogan JZ; Lawrence RE; Boone M; Wuerth JD; Frost A; Walter P
Nat Commun; 2021 Dec; 12(1):7103. PubMed ID: 34876554
[TBL] [Abstract][Full Text] [Related]
11. Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.
Wek RC; Anthony TG; Staschke KA
Antioxid Redox Signal; 2023 Aug; 39(4-6):351-373. PubMed ID: 36943285
[No Abstract] [Full Text] [Related]
12. eIF2B-capturing viral protein NSs suppresses the integrated stress response.
Kashiwagi K; Shichino Y; Osaki T; Sakamoto A; Nishimoto M; Takahashi M; Mito M; Weber F; Ikeuchi Y; Iwasaki S; Ito T
Nat Commun; 2021 Dec; 12(1):7102. PubMed ID: 34876589
[TBL] [Abstract][Full Text] [Related]
13. Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound.
Sekine Y; Zyryanova A; Crespillo-Casado A; Fischer PM; Harding HP; Ron D
Science; 2015 May; 348(6238):1027-30. PubMed ID: 25858979
[TBL] [Abstract][Full Text] [Related]
14. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.
Herrero M; Daw M; Atzmon A; Elroy-Stein O
Cells; 2021 Jul; 10(8):. PubMed ID: 34440627
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis screen uncovers lifespan extension through integrated stress response inhibition without reduced mRNA translation.
Derisbourg MJ; Wester LE; Baddi R; Denzel MS
Nat Commun; 2021 Mar; 12(1):1678. PubMed ID: 33723245
[TBL] [Abstract][Full Text] [Related]
16. Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases.
Craig RA; De Vicente J; Estrada AA; Feng JA; Lexa KW; Canet MJ; Dowdle WE; Erickson RI; Flores BN; Haddick PCG; Kane LA; Lewcock JW; Moerke NJ; Poda SB; Sweeney Z; Takahashi RH; Tong V; Wang J; Yulyaningsih E; Solanoy H; Scearce-Levie K; Sanchez PE; Tang L; Xu M; Zhang R; Osipov M
J Med Chem; 2024 Apr; 67(7):5758-5782. PubMed ID: 38511649
[TBL] [Abstract][Full Text] [Related]
17. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
Mao D; Reuter CM; Ruzhnikov MRZ; Beck AE; Farrow EG; Emrick LT; Rosenfeld JA; Mackenzie KM; Robak L; Wheeler MT; Burrage LC; Jain M; Liu P; Calame D; Küry S; Sillesen M; Schmitz-Abe K; Tonduti D; Spaccini L; Iascone M; Genetti CA; Koenig MK; Graf M; Tran A; Alejandro M; ; Lee BH; Thiffault I; Agrawal PB; Bernstein JA; Bellen HJ; Chao HT
Am J Hum Genet; 2020 Apr; 106(4):570-583. PubMed ID: 32197074
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease.
Herstine JA; Chang PK; Chornyy S; Stevenson TJ; Sunshine AC; Nokhrina K; Rediger J; Wentz J; Vetter TA; Scholl E; Holaway C; Pyne NK; Bratasz A; Yeoh S; Flanigan KM; Bonkowsky JL; Bradbury AM
Mol Ther; 2024 Jun; 32(6):1701-1720. PubMed ID: 38549375
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the interactions of eIF2β with eIF5, eIF2B, and 5MP1 and their regulation by CK2.
Wagner PA; Song M; Ficner R; Kuhle B; Marintchev A
bioRxiv; 2024 Apr; ():. PubMed ID: 38712236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
